Skip to main content

Table 2 Immunodeficiencies among 101 COVID-19 survey respondents

From: Understanding attitudes and obstacles to vaccination against COVID-19 in patients with primary immunodeficiency

Type of primary immunodeficiency disorder Percentage (%) Responses*
Common variable immunodeficiency (CVID) 72.3 73
Hypogammaglobulinemia 10.9 11
Immunoglobulin deficiency (IgA, IgA1, IgG, IgG2, IgG3, IgM) 6.9 7
STAT1 deficiency 2.0 2
B cell dysfunction 1.0 1
Chronic lymphocytic leukemia (CLL) 1.0 1
IPEX syndrome 1.0 1
Severe combined immunodeficiency disease (SCID) Omenn Syndrome RAG1 1.0 1
Secondary hypoglobulinemia 1.0 1
Secondary immunodeficiency 1.0 1
HLA-B27 autoimmune disease 1.0 1
Dysgammaglobulinemia 1.0 1
  1. Data from COVID-19 Vaccine Hesitancy Survey in Primary Immunodeficiency Patients, March 24 to April 7, 2021
  2. *Three non-specific responses were excluded from the estimations
  3. CLL chronic lymphocytic leukemia, CVID common variable immunodeficiency, HLA-B27 human leukocyte antigen B27, Ig immunoglobulin, IPEX immunodysregulation polyendocrinopathy enteropathy X-linked, RAG1 recombination activating 1 gene, SCID severe combined immunodeficiency disease, STAT1 signal transducer and activator of transcription 1